JNJ JOHNSON & JOHNSON Management Changes 8-K Filing 2023 - Departure of Directors Thibaut Mongon will cease to be EVP of Johnson & Johnson and continue as CEO of Kenvue Inc. Shareholders approved director nominees, executive compensation, and appointment of PwC as independent auditor, but did not approve shareholder proposals for a Vaccine Pricing Report and a report on the Impact of Extended Patent Exclusivities on Product Access.Get access to all SEC 8-K filings of the JOHNSON & JOHNSON